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Abstract – The complement component C3 plays an essential role in the activated complement
system, which is involved in phagocytosis, inﬂammation and immunoregulation to destroy
infectious microorganisms. The C3 molecule has more implications in the general defence
mechanisms. Inthisstudy,theporcineC3cDNAsequencesincluding50-and30-ﬂankingregions
were determined and the polymorphisms in this gene were identiﬁed to carry out an association
analysis between C3 and complement activity traits. Porcine C3 gene has high homology with
human C3. Five single nucleotide polymorphisms (SNPs) and one microsatellite were detected
in the porcine C3 gene. Haemolytic complement activity of alternative and classical pathways
(ACH, CCP) was measured in 416 F2 animals of a crossbred of Duroc  Berlin Miniature Pig,
which were immunized with Mycoplasma, Aujeszky and PRRS vaccines. C3 markers were
found to be signiﬁcantly associated (P < 0:05) with both ACP and CCP. Animals with the more
frequent haplotype present in Duroc and other commercial breeds exhibit higher ACP and CCP
levels than the animals with haplotype speciﬁc to some Berlin Miniature Pigs. The association
of C3 with complement activity reinforces the importance of C3 as a candidate gene for natural
resistance to microorganisms.
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1. INTRODUCTION
The complement cascade deﬁnes an important link between the innate and
the speciﬁc immune system [13]. The complement component C3 is the key
molecule of the three pathways of complement activation (alternative, clas-
sical and lectin pathways), which are involved in phagocytosis, inﬂammation
and immunoregulation processes to destroy infectious microorganism [19].
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C3 deﬁciency in hosts causes increasing susceptibility to bacterial or viral
infections [1,4,13,22]. C3 has more implication in general defence mechan-
isms. WehavepreviouslyfoundpolymorphicsiteswithintheporcineC3which
were used for geneticmapping of the locus[25]. The presentstudy was carried
out to investigate the porcine C3 gene as a candidate gene for complement
activity traits. Therefore, the full length cDNA sequence of the porcine C3
as well as 50-a n d3 0- ﬂanking regions were obtained, screened for additional
polymorphisms in this gene and, ﬁnally, association analysis was conducted
between C3 markers and complement activity traits.
2. MATERIALS AND METHODS
2.1. Animals
Sequence information of the porcine C3 gene was identiﬁed in a DUMI F2-
animal of a reciprocal cross of Duroc  Berlin Miniature Pig [9]. Screening
for polymorphisms in the porcine C3 gene was performed in Duroc (n D 6),
German Landrace (n D 28), Pietrain (n D 23), DUMI F2 (n D 902) and Thai
native (n D 32) pigs. For association study, haemolytic complement activity
was recorded in 416 animals of the DUMI-F2 resource population.
2.2. cDNA sequence and 50 and 30 ﬂanking regions
of the porcine C3 gene
Total RNA was extracted from pig liver using TRIzolTM Reagent (Life
Technologies, Karlsruhe, Germany). Full length porcine C3 cDNA sequence
was determined by the SMARTTM RACE cDNA Ampliﬁcation Kit (Clontech,
Heidelberg,Germany). RACEprimersandgenespeciﬁcprimersweredesigned
basedon partialporcineC3 sequenceinformation(GenBankaccessionnumber
AF110278, F14640) (Fig. 1):
RACE: 50-ctaatacgactcactatagggcaagcagtggtatcaacgcagagt-30
C3-A2: 50-ccttctccacgacatcccagatcctacg-30
C3-B1: 50-ccaccaagaccatgaatgtg-30
C3-B2: 50-tagagcttctggccaggttc-30
C3-C1: 50-ggtggtgaccatgtaccacg-30:
The 50and 30 ﬂanking regions of porcineC3 gene were isolatedfrom a genomic
DNA library, which was constructed using Lambda DASH II® (Stratagene,
Amsterdam, Netherlands). Two positive clones of 50 and 30 ﬂanking region
were ampliﬁed with primers speciﬁc to porcine C3 (50-ﬂanking region 50-
tgtgccccttctctgatttg-30,3 0-ﬂankingregion50-gctccgatgaagtgcaggt-30)andT3/T7Association of complement activity and C3 gene S85
 AAAAAA 
A

 A  A 
	
  	 

 

 


 
Figure 1. Ampliﬁcation of the full-length porcine C3 gene. Three PCR fragments
(A, B and C) were ampliﬁed with primers based on available porcine C3 sequence in
GenBank,a580-bppartialcDNAfragment(shadedarea1)(accessionNo. AF110278)
and a 462-bp EST of porcine C3 (shaded area 2) (accession No. F14640).
standard primers. All the PCR fragments were ligated in pGEM®-T vector
(Promega, Mannheim, Germany) and sequenced using the SequiTherm Excel
cycle sequencing Kit (Epicentre Technologies, Biozym, Hessisch Oldendrof,
Germany) and a LI–COR 4200 automated sequencer (LI–COR Biosciences,
Bad Homburg, Germany).
2.3. Polymorphism screening and marker genotyping
To identify polymorphisms in the porcine C3 gene, oligonucleotide primers
were designed revealing 17 overlapping PCR fragments (Tab. I). They were
ampliﬁed from individual liver cDNA and genomic DNA of six pig breeds.
PCR was performed in a 25 mL reaction volume containing 50 ng of liver
cDNA, 0:2 mM of each primers, 50 mM each dNTPs, 0.5 U of Pfu polymerase
(Promega) in 1 Pfu-PCR buffer. PCR cycling program was 94 Cf o r3m i n ,
followed by 35 cycles of 94 C for 30 s, 52–60 C (Tab. I) for 30 s, 72 C
for 1 min and ﬁnal extension at 72 C for 5 min. PCR products were gel
puriﬁed, clonedandsequenced. The nucleotidesequencesof eachanimalwere
compared to ﬁnd out polymorphisms in the porcine C3 gene.
To genotype each polymorphic site in the porcine C3 gene, PCR-RFLP,
allele speciﬁc PCR, SSCP and microsatellite analysis were performed. Oli-
gonucleotide primers (Tab. II) were used to amplify PCR fragments from
genomic DNA. PCR reactions were carried out in 20 mL volume using Taq
polymerase (Promega). Ampliﬁed PCR fragments with primer C3-I (Tab. II)
were mixed with 1:10 with loading buffer (95% formamide, 10 mM NaOH,
0.25% bromophenol blue, 0.25% xylenecyanol), denatured at 95 Cf o r5m i n ,
then cooled on ice immediatelyand separatedon 12% polyacryamidegel (49:1
acrylamide/bis-arylamide)at room temperaturewith a constant 12 W for 6 h in
0.5 TBE. The SSCP-bands were stained by silver staining procedure. Ampl-
icon C3-II was digested with restrictionenzyme TaqI (Promega). The digested
PCRfragmentswereanalysedon2%agarosegels. GenotypingtheSNPswithin
amplicons C3-III and C3-IV was done as described previously [25]. Frag-
ments with length polymorphism were ampliﬁed with primer C3-V (Tab. II)
and were identiﬁed on 6% SequiGel®XR-denaturating polyacrylamide gelsS
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Table I. Primer sequences used for screening polymorphisms in the porcine C3 gene.
Name Forward primer sequence
(50 to 30)
Reverse primer sequence
(50 to 30)
Annealing
temp. ( C)
cDNA
(bp)
Genomic-
DNA
(bp)
C3–50 GCATCGACTTGAATTCACAG CCATGATGGAGGGACGGTG 55 – 477
C3–01 TCCTTTCCCTCTGTCCCTTT GGGAGTCCCGTTTGATGTC 58 577 –
C3–02 TGAGACACCTGAAGGCATTG GCTGTTCCATCCACACTCTC 58 306  700
C3–03 TCAACATCATTGCCAGGTTC GGGTCTTGGTGAAGTGGATC 59 324 –
C3–04 CATCGTGACCTCCCCCTATC GTGCGCAGGTGGAAGTTAAC 59 393  1000
C3–05 TCAAGCCAGGGGAGAATCTC TCTCCAGGGTCATCTGTTGC 56 360  1500
C3–06 GAAGCAAGACAAGCAGCATC TGTCCATCCTTTTCTCCATG 56 338  900
C3–07 GTGCAGCTCATGGAGAAAAG ATTCATGGTCTTGGTGGAG 56 360 –
C3–08 CTCCACCAAGACCATGAAT TCTTCAAGGGCACAATG 54 356 –
C3–09 CATTGTGCCCTTGAAGA GTGCTGTCCAGGTAGTGC 55 396 –
C3–10 CAGTCATCGCTGTGCACTA GTTCTTGAAGCCACCAATC 55 343 –
C3–11 GATTGGTGGCTTCAAGAAC CTACCAGCAGAGCCAAG 52 341 –
C3–12 CTTGGCTCTGCTGGTAG CGTGGTACATGGTCAC 52 338  1000
C3–13 GTGACCATGTACCACG CCTCCAGGGTGTGTGAGAC 52 337  1300
C3–14 GATCTCACACACCCTGGAGG CACTTCATCGGAGCCTGATT 55 379 –
C3–15 AATCAGGCTCCGATGAAGTG GGCAACCAAAGACGACCAT 56 270 –
C3–30 TGGCCAACTTCTCTGAGAAC TGCAGGCAGATACAGTTGAG 60 – 530Association of complement activity and C3 gene S87
Table II. Nucleotide sequence primers for genotyping the polymorphisms in the
porcine C3 gene.
Amplicon Primer (50 to 30) Size (bp) Annealing
temp. ( C)
C3-I F: GCATCGACTTGAATTCACAG 477 55
R: CCATGATGGAGGGACGGTG
C3-II F: CACCCTGATTGCTGCCAATG 383 60
R: TACCTCAACTTACTGCGGTC
C3-III F: TGAGAATGTGGATGGACCAG 384 60
R: GGACTTGAATGCCCAAGATC
C3-IV F1: AAGGATCTGAACCTGGATGTA 454 64
F2: GGATCTGAACCTGGATGTG 452
R: ACCCCGCTAATCTGTGATGC
C3-V F: TGGCCAACTTCTCTGAGAAC 204, 207 60
R: TAGGATGAACCTGAGCTGTG 211
(Biozym Diagnostik GmbH) by the LI-COR 4200 automated sequencer (LI-
COR Biosciences). The fragment size of alleles was analysed by One-Dscan
software (Scanalytics, MWG Biotech).
2.4. Haemolytic complement activity phenotypes
Total haemolytic complement activities were determined in 416 F2-animals
oftheDUMI-resourcepopulationproducedfrom11F1sows(2full-sibgroups)
mated with 3 F1 boars. The animals were reared in the Frankenforst research
farm of the University of Bonn. They were immunized with Mycoplasma,
Aujeszky and PRSS vaccines at 6, 14 and 16 weeks of age, respectively. Blood
samples were taken immediately before vaccination and on 4 and/or 10 days
aftervaccination(Fig.2). Totalhaemolyticactivityofthealternative(ACP)and
classical complement pathway (CCP) was determined by a method modiﬁed
from Liu and Young [15]. Non sensitised rabbit erythrocytes and sensitised
sheep erythrocytes were used as target cells, for ACP and CCP respectively.
The haemolytic complement activity was expressed as the titre that lysed 50%
of erythrocytes (CH50 unit  mL−1).
2.5. Association analysis between C3 and complement activity traits
Association between C3 markers and haemolytic complement activity traits
was analysed using the REPEATED statement of the SAS® PROC MIXED
procedure [14]. The statistical model included C3 genotype, time of bloodS88 S. Mekchay et al.
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Figure 2. Vaccination programme and time of blood sampling in the DUMI-F2
resource population.
sampling, sire, and interaction of C3 genotype and time of blood sampling as
ﬁxed effects, and dam nested within sire as random effect. A heterogeneous
compound-symmetry(CSH)covariancestructurewasincludedinthestatistical
model to analyse ﬁxed effects because it gave the best ﬁt when compared to
other covariance structures.
3. RESULTS
3.1. Sequence analysis of the porcine C3 gene
The complete porcine C3 cDNA sequence (accession No. AF154933) was
determined. The 5127 bp cDNA contains an open reading frame coding for
1661 amino acids, including a 22-amino acids signal peptide, 643 amino
acids b-chain, a 4 amino acids linker and 992 amino acids a-chain. The
ORF of porcine C3 shows 80, 78 and 77% homology with human, rat and
mouse C3 nucleotide sequence, respectively [6,7,17]. The 63 bp 50-UTR
is a pyrimidine rich region (approximately 80% pyrimidines). A 56 bp of
30-UTR was sequenced and a polyadenylation signal (AATAAA) was found
at position 5074 to 5079 of cDNA sequence (AF154933). The sequence
information of the 50-ﬂanking region (Fig. 3a) contained several features of
promoter region. The putative TATA-box (GATAAA) sequence was located at
−29 bp of the ﬁrst nucleotide C3 sequence (AF154933) and various putative
enhancer/transcription factor binding sequences were also found (Tab. III).
Comparison of the porcine 50-ﬂanking sequence with the promoter region of
human C3 sequence (X62904) [10] revealed 74% sequence identity. However,
the 30-ﬂanking region (Fig. 3b) of porcine C3 had low homology with human
C3 sequence (M63422) [21].
3.2. Polymorphism and allelic frequency of the porcine C3 gene
Six polymorphic sites were found in the porcine C3 gene including ﬁve
SNPs and one microsatellite(Fig. 4a). Two SNPs werefound inthe 50-ﬂankingAssociation of complement activity and C3 gene S89
-487 GACTCTTGCT GCCAGCATCG ACTTGAATTC ACAGGAAGGG TTTGGTTAAT
-437 AAGTGCATGG CCAAAAGTGG ACTGAGAGCC AGGTGCAGAT ATCGGGGAAG
-387 GGGGGCAGGC ACTATCTGGG GAAGAGAGAA TAATTTTCCT CCACTACAAA
-337 GTGGGTATAG CAGGGACAGG TCCCCATTCA CCAGCCAGCC TTGACCATGA
-287 GAGAGGCCAG GGCAGGAGGC TGTTGTATTC TTGTTGCAGG AGGACGTGCC
-237 CTTAGGTTAT TTTCCCCAGG ACTGTGATGG CCACACAGAT TGAAAAACTT
-187 TGGAAATGAC ATTGAGAAAT CTGGGGCAGC CCCAGGGAGG GGGGAGGCCA
-137 CAGGGAGTGG AGGGCTGGGC TGAAGAGGGG GAAAAGCAGC TGCCAGATAA
-087 AAGGCAGCCT CCAGCAGCCT CTGCTCACTT CCCCCCCCAC CCCCGTCCTT
-037 TCCCTCTGTC CCTTTGTCCC TCCACCGTCC CTCCATCATG ..........
.......... .......... .......... .......... ..........
... C3 cDNA sequence in GenBank accession F154933 ....
......................................................
1 TGATGCCACT CCCCCACAGT CTACCCAATA AAGCTCCAGT TATCTTTCAC
51 ATTTCCCCCC ACATCTGAAG GTCTTTTTTT TTTTTTTTTT GAAGGTCTTT
101 GAGAGGGGAA AAGAGGCAGC TGTGATCCCG CCACTGCCTC ACCCACAGCT
151 CAGGTTCATC CTACTGAAAC TCCACCTGCT TCCCACTTCA TCCCCTCCAG
201 CAGTTCACCC GGCTTCCTGG CCTCAAGTGC ATGTACCTGC CTTACCTGCA
251 CCTAGCGGGC AGTACATCTG CAGCTTCCCC TGCATCTCCC CTGCACCCCC
301 ATCCTTACCC AAATTCTCAT TTACATTCTC ACCTGCATCC TCCCCAGCAG
351 CTCACTGTCC CTTCACCTGA GCTTTCACCA CCTTGCTTAC CTACCTCCTT
401 ATTTCATCCT CACCTGAGCT TTTCCCAATA GTCTCAGCTG AATCTTCACC
451 CTCTCTCACC TGCACACTCA ACTGTATCTG CCTGCATTTT CTGCATCTTC
501 CCTGCTTCCC CCACCTACAT CTTAATCTGT AAACTTAACT GTATCTCTAC
551 CAACATTCTT TCCTTTATTC TCACCTTGTC TTTCTACCTG TATCCTTACC
601 TGTATTTTCT CTGCATCCTC CTCAGGGTGA GGAACTGCAT CTTTGCCTAC
651 ATCCCTCTCT AGTCTCTTTC CTGTGTTCTC ACCAGCATCC TTAGCTACAT
701 TCTCACCTAC ATCTTCCCCT GCATCTTTTT TTTGCTTTTT TTTTTTTTGC
751 TTTTTTTTTG CTTTTTAGGG CCACACCCAC GGCATATGGA GGTTCCCAAG
801 CTAGGGGGCA AATTGGAGCT GCAGCTGCCA GCCTCACCAC AGCCACATCA
851 ATGCAGGATC CGAATTCTTC GCCCTATAGT GAGT
 
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Figure 3. Sequence of the 50-ﬂanking region upstream from ATG start codon (a)
and of the 30-ﬂanking region downstream from TGA codon (b) of the porcine C3
gene (accession No. F154933). The 50-UTR is indicated in italics and the putative
transcription start site is indicated in italics, bold and underlined. A putative TATA
box and polyadenylation signal are indicated in bold and underlined in the 50-a n d
30-ﬂanking regions, respectively.
region at position −384 (G > A) and −44 (C > T) nucleotide (nt) upstream
ATG start codon. The other three SNPs were located in the coding region at
1905 (C > A), 3882 (G > A) and the nt 204 (T > C) of the intron 13. A
microsatellite with .T/14-21-repeat units was found in the 30-ﬂanking region of
C3 and was located at 71 bp downstream from the TGA stop codon.
The two SNPs of 50-ﬂanking region were genotyped by SSCP analysis
(Fig. 4b). Taq I-RFLP was used to detect the variation of the nt 204 in
the intron 13 of C3-cDNA sequence (amplicon C3-II) and showed either
undigested PCR product (384 bp, allele T), and/or digested product (285 bp
and 143 bp, allele C) (Fig. 4c). Similarly, restrictionenzyme Hsp92 I was used
to test polymorphism at position 1502 (amplicon C3-III) and revealed eitherS90 S. Mekchay et al.
Table III. Position of transcription factor binding sites in the 50-ﬂanking region of the
porcine C3 gene.
Factor Consensus sequence Position Homology (%) Ref.
Enhancer core GGGGAAAA −110 to −103 88 [8]
C/EBP TTGAGAAAT −176 to −168 100 [23]
IL-6-RE AGGGGGA −112 to −106 86 [21]
TCTGGGG −168 to −162 100 [21]
TGAGAAA −175 to −169 100 [21]
TGAAAAA −197 to −191 100 [21]
TGAGAGA −290 to −284 100 [21]
TGGGGAA −371 to −365 100 [21]
IL-6 RE rev TTCCCCA −220 to −226 100 [8]
TCCTCCA −351 to −345 100 [8]
IFNgRE GAAAAACTTTGGAAA −196 to −192 87 [8]
AP-2 CCCTTAGG −132 to −139 88 [18]
LF-A1 TGGCCA −210 to −205 83 [8]
TGGACT −420 to −415 83 [8]
LF-B1/HNF-1 GTTAAT −443 to −438 100 [8]
GTTATT −232 to −227 83 [8]
Estrogen RE TGTCCCTTTGTCC −31 to −19 85 [21]
digested PCR product (237 bp and 146 bp, allele C) and/or 383 bp (alleleA) of
undigestedproduct(Fig.4d). TheSNPlocatedat3882wasgenotypedbyallele
speciﬁc PCR technique with two different primer sets (Fig. 4e). Microsatellite
analysis in the 30-ﬂanking region of porcine C3 revealed three alleles of 211,
207 and 204 bp (amplicon C3-V), and these alleles corresponded to .T/21-,
.T/17-, and .T/14-repeat units, respectively (Fig. 4f, allele 204 not shown).
Five of these polymorphic sites (at positions −44, 204 of intron 13, 1509,
3882 and C71) were segregating in the DUMI F2-resource population, and
these alleles were coming from some Berlin Miniature Pig of the grandparent
generation. All six polymorphic sites were segregating only in Thai native
pigs, but no polymorphism was found among the 86 Duroc, German Landrace,
Large White and Pietrain pigs. Allelic frequencies of the polymorphic sites in
porcine C3 gene among pig breeds are given in Table IV.
3.3. Association analysis
Means and standard deviation of the haemolytic complement activity of
alternative and classical pathways were estimated (Tab. V). Only 3 SNPsAssociation of complement activity and C3 gene S91
Figure 4. Polymorphism in the porcine C3 gene including the 50-a n d3 0-ﬂanking
regions (a); SSCP analysis at positions −384 and −44 bp in the 50-ﬂanking region (b);
TaqI- PCR-RFLP test at position 204 in intron 13 (c); Hsp92 I-PCR-RFLP test at
position 1905 (d); allele speciﬁc PCR test at position 3882 (e); and SSLP analysis at
position C71 bp in the 30-ﬂanking region (f).
and one microsatellite (nt 204 of intron 13, 1905, 3882, C71) were gen-
otyped. These four alleles were segregating with two haplotype patterns
that can be described [2] as follows: allele C3*1, [IVS13C204T; 1905C;
3882G; c.5038C71.T/21] and allele C3*2, [IVS13C204C; 1905A; 3882A;
c.5038C71.T/17]. The numbers of pigs for each genotype class were 290, 109
and 17 for C3*1/C3*1, C3*1/C3*2 and C3*2/C3*2 genotypes respectively.
Subsequently,thegenotypeC3*2/C3*2wasexcludedfromtheanalysisbecause
of its low frequency and unequal distribution over parities and litters.S92 S. Mekchay et al.
Table IV. Allele frequencies at the porcine C3 gene in six genetic groups of pigs.
Position Allele Frequency
F2-
DUMI
Duroc German
Landrace
Large
White
Pietrain Thai
native pig
−384 G 1.00 1.00 1.00 1.00 1.00 0.99
−44 G 0.99 1.00 1.00 1.00 1.00 0.97
204 (intron 13) T 0.75 1.00 1.00 1.00 1.00 0.82
1905 C 0.74 1.00 1.00 1.00 1.00 0.70
3882 G 0.74 1.00 1.00 1.00 1.00 0.82
C71.T/21 T21 0.76 1.00 1.00 1.00 0.00 0.71
C71.T/17 T17 0.24 0.00 0.00 0.00 0.00 0.12
C71.T/14 T14 0.00 0.00 0.00 0.00 0.00 0.17
Table V. Haemolytic complement activities (mean  SD) of alternative and classical
pathways in DUMI resource population.
Haemolytic complement activity (Unit  mL−1)
Blood sampling ACH50 CCH50
Time-1 53:64  28:31 40:70  23:13
Time-2 53:22  28:43 48:23  28:81
Time-3 55:05  24:86 47:97  29:19
Time-4 56:86  30:13 59:08  36:46
Time-5 62:31  32:08 64:91  35:71
Time-6 68:46  47:63 59:79  39:10
Time-7 69:75  41:70 62:53  35:58
Time-8 69:71  37:42 60:99  40:89
Table VI. Signiﬁcance in analysis of variance of alternative (ACH50) and classical
(CCH50) complement activity traits.
Test of ﬁxed effects (P value)
Traits C3 marker Time C3  time Sire
ACH50 0:0255 < 0:0001 < 0:0001 < 0:0001
CCH50 0:0286 < 0:0001 0:0014 0:0151
Analysis of variance revealed that hemolytic complement activity of both
alternative and classical pathways was signiﬁcantly affected (P < 0:05) by C3
marker,timeofbloodsamplingandtheirinteraction,andbysireeffect(Tab.VI).
The proﬁles of the haemolytic complement activities between the different C3Association of complement activity and C3 gene S93
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Figure 5. Haemolytic complement activity proﬁles of alternative (a) and classical (b)
pathways for pigs with C3*1/C3*1 and C3*1/C3*2 haplotypes.
genotypes were not parallel over time (Fig. 5). Complement activities in the
alternative and classical pathway were 5.8 and 6:9 units  mL−1 higher for
animals homozygous for the C3*1 allele than for C3*1/C3*2 animals.
4. DISCUSSION
Activated complement systemplaysan importantrolein killingand neutral-
izationof microorganisms, andC3 is a key moleculeof thissystem. Therefore,
C3 can be regarded as a candidate gene for complement activities. The 5.1 kb
sequence of full-length porcine C3 gene has a 4983-bp ORF which coded
for a-a n db-chain of C3 protein. The porcine C3 is a conserved gene and
has high homology with the other mammalian species C3 gene. Indeed, the
putative promoter region contains one TATA-box and several cis-regulatingS94 S. Mekchay et al.
elements similar to that of the human C3 promoter [8,21]. The variation
of haemolytic complement activities before and after vaccination within the
F2-DUMI resource population was found to be associated with C3 markers.
Although these C3 markers were silent at the amino acids level, another
nucleotide exchange in the 50-ﬂanking promoter region of the C3 gene and
in linkage disequilibrium with these C3 variants might be responsible for its
function. Animals with the more frequent C3*1/C3*1 haplotype, present in
Duroc and other commercial breeds, exhibited higher complement reactivity
than those carrying the allele C3*2 coming from Berlin Miniature Pigs.
GeneticvariationinC3 affectingthecomplementactivityhasbeenobserved
in human [3], rabbit [11], and mouse [5]. These reports indicated that the
genetic defect of C3 gene caused low (or lack of) haemolytic complement
activity and increased susceptibility to microorganisms. Phenotypic variation
of haemolytic complement activity in pigs has been associated with effects
due to vaccination, genomic variation at the swine leukocytes antigen locus
(SLA) [16,20], breed [12], age as well as sire or/and dam [16,24].
Although the complement is a complex system and is controlled by many
genes, the present work showed there was an association of C3 and haemolytic
complement activity – a defence mechanism active against many pathogenic
agents – which reinforces the importance of C3 as a candidate gene for natural
resistance to microorganisms.
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